Radiotherapy & Oncology
Volume 96, Issue 3 , Pages 275-276 , September 2010

PET in radiotherapy planning: Particularly exquisite test or pending and experimental tool?

  • Vincent Gregoire

      Affiliations

    • Radiation Oncology Department, Université catholique de Louvain, Brussels, Belgium
    • Corresponding Author InformationCorresponding author. Address: Radiation Oncology Department and Laboratory of Molecular Imaging and Experimental Radiotherapy, Université catholique de Louvain and St-Luc University Hospital, 10 Ave. Hippocrate, 1200 Brussels, Belgium.
    • ,
  • Arturo Chiti

      Affiliations

    • Nuclear Medicine Department, Humanitas, Milan, Italy

Received 13 July 2010 ,Accepted 15 July 2010.

References 

  1. ICRU. International Commission on Radiation Units and Measurements. Prescribing, recording and reporting Intensity-Modulated Photon-Beam Therapy (IMRT). In: ICRU Report 83, J. ICRU. Oxford: Oxford University Press.
  2. Thorwarth D, Alber M. Implementation of hypoxia imaging into treatment planning and delivery. Radiother Oncol. 2010;
  3. Moule RN, Kayani I, Mouddin SA, Meer K, Lemon C, Goodchild K, et al. The potential advantages of 18FDG PET/CT-based target volume delineation in radiotherapy planning of head and neck cancer. Radiother Oncol. 2010;
  4. Muijs CT, Beukema JC, Pruim J, Mul VE, Groen H, Plukker JT, et al. A systematic review on the role of FDG-PET/CT in tumour delineation and radiotherapy planning in patients with esophageal cancer. Radiother Oncol. 2010;
  5. Henriques de Figueiredo B, Barret O, Demeaux H, Lagarde P, De-Mones-Del-Pujol E, Kantor G, et al. Comparison between CT- and FDG-PET-defined target volumes for radiotherapy planning in head-and-neck cancers. Radiother Oncol. 2009;93:479–482
  6. Seppälä J, Seppänen M, Arponen E, Lindholm P, Minn H. Carbon-11 acetate PET/CT based dose escalated IMRT in prostate cancer. Radiother Oncol. 2009;93:234–240
  7. Muijs CT, Schreurs LM, Busz DM, Beukema JC, van der Borden AJ, Pruim J, et al. Consequences of additional use of PET information for target volume delineation and radiotherapy dose distribution for esophageal cancer. Radiother Oncol. 2009;93:447–453
  8. Schinagl DA, Hoffmann AL, Vogel WV, van Dalen JA, Verstappen SM, Oyen WJ, et al. Can FDG-PET assist in radiotherapy target volume definition of metastatic lymph nodes in head-and-neck cancer?. Radiother Oncol. 2009;91:95–100
  9. MacManus M, Nestle U, Rosenzweig KE, Carrio I, Messa C, Belohlavek O, et al. Use of PET and PET/CT for radiation therapy planning: IAEA expert report 2006–2007. Radiother Oncol. 2009;91:85–94[Review]
  10. Nguyen BT, Joon DL, Khoo V, Quong G, Chao M, Wada M, et al. Assessing the impact of FDG-PET in the management of anal cancer. Radiother Oncol. 2008;87:376–382
  11. van Loon J, Offermann C, Bosmans G, Wanders R, Dekker A, Borger J, et al. 18FDG-PET based radiation planning of mediastinal lymph nodes in limited disease small cell lung cancer changes radiotherapy fields: a planning study. Radiother Oncol. 2008;87:49–54
  12. Ollers M, Bosmans G, van Baardwijk A, Dekker A, Lambin P, Teule J, et al. The integration of PET–CT scans from different hospitals into radiotherapy treatment planning. Radiother Oncol. 2008;87:142–146
  13. Haubner R. PET radiopharmaceuticals in radiation treatment planning: synthesis and biological characteristics. Radiother Oncol. 2010;96:280–287
  14. Sattler B, Lee JA, Lonsdale M, et al. PET/CT (and CT) instrumentation, image reconstruction and data transfer for radiotherapy planning. Radiother Oncol. 2010;96:288–297
  15. Coffey M, Vaandering A. Patient setup for PET-CT acquisition in radiotherapy planning. Radiother Oncol. 2010;96:298–301
  16. Weber WA. Quantitative analysis of PET studies. Radiother Oncol. 2010;96:308–310
  17. Bettinardi V, Picchio M, Di Muzio N, et al. Detection and compensation of organ/lesion motion using 4D-PET/CT respiratory gated acquisition techniques. Radiother Oncol. 2010;96:311–316
  18. Lee JA. Segmentation of positron emission tomography images: some recommendations for target delineation in radiation oncology. Radiother Oncol. 2010;96:302–307
  19. Thorwarth D, Geets X, Paiusco M. Physical radiotherapy treatment planning based on functional PET/CT data. Radiother Oncol. 2010;96:317–324
  20. Chiti A, Kirienko M, Gregoire V. Clinical use of PET–CT data for radiotherapy planning: What are we looking for?. Radiother Oncol. 2010;96:277–279
  21. Grosu AL, Weber WA. PET for radiation treatment planning of brain tumours. Radiother Oncol. 2010;96:325–327
  22. Troost ECG, Schinagl DAX, Bussink J, et al. Clinical evidence on PET–CT for radiation therapy planning in head and neck tumours. Radiother Oncol. 2010;96:328–334
  23. De Ruysscher D, Kirsch C-M. PET scans in radiotherapy planning of lung cancer. Radiother Oncol. 2010;96:335–338
  24. Lambrecht M, Haustermans K. Clinical evidence on PET–CT for radiation therapy planning in gastro-intestinal tumors. Radiother Oncol. 2010;96:339–346
  25. Pichio M, Giovannini E, Crivellaro C, et al. Clinical evidence on PET–CT for radiation therapy planning in prostate cancer. Radiother Oncol. 2010;96:347–350
  26. Haie-Meder Ch, Mazeron R, Magné N. Clinical evidence on PET–CT for radiation therapy planning in cervix and endometrial cancers. Radiother Oncol. 2010;96:351–355

PII: S0167-8140(10)00422-6

doi: 10.1016/j.radonc.2010.07.015

Radiotherapy & Oncology
Volume 96, Issue 3 , Pages 275-276 , September 2010

Article Tools